Tests home blood pressure monitoring with pharmacist help in older adults with chronic diseases
Tests home blood pressure checks with pharmacist help in older adults with several conditions.
Key facts
- Who runs it
- Korey Kennelty
- Where
- Iowa City, United StatesSee the 2 sites
- Trial code
- Registry title
- SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
- Status
- Recruiting
- People taking part
- 930 people, planned
- Started
- 1 Jul 2025
- Expected to end
- 1 May 2031
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- SMBP with clinical pharmacist support
- Record updated
- 15 October 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 65 or older with high blood pressure. It tests home blood pressure checks, with or without extra support from a clinical pharmacist.
- Age
- 65 years or older
- Sex
- All sexes can join.
- Disease stage
- High blood pressure: a six-month average systolic blood pressure of 145 mmHg or higher in the medical record, and 140 mmHg or higher at the baseline clinic visit.
- Earlier treatment
- Seen at least once in the clinic or healthcare system in the previous 12 months. Plans to keep receiving care there for the next 24 months.
Main reasons for not taking part
- In hospice care or referred to hospice
- Lives in a nursing home, skilled nursing, rehabilitation or memory care facility
- Cannot give informed consent
- Cannot communicate in English or Spanish
- In active chemotherapy or radiation treatment for cancer
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- The patient is at least 65 years of age
- Patient is seen at least once in clinic or healthcare system in the previous 12 months
- Patient has a six-month average (non-acute/maintenance) systolic blood pressure (SBP) >= 145 mmHg, documented in the electronic medical record in last six months
- Patient has a baseline in-clinic visit systolic blood pressure (SBP) >= 140 mmHg
- Patient plants to receive care from participating healthcare system for the next 24 months
Who cannot take part
- The patient is in active chemotherapy or radiation treatment for cancer
- The patient is enrolled in hospice or has an active referral to hospice care
- The patient resides in a nursing home, in skilled nursing, rehabilitation facility, or memory care
- The patient is not capable of providing informed consent
- The patient is unable to communicate in English or Spanish
- The patient is pregnant or has plans to become pregnant
- The patient is currently participating in another study focused on blood pressure
- The patient does not have a telephone
Where in United States
- University of IowaIowa City, United StatesContact: Korey Kennelty, PharmD, PhDNot yet recruiting
- University of Iowa Health CareIowa City, United StatesContact: Korey Kennelty, PharmD, PhDTaking people
About the trial
What the trial wants to find out
Nearly half of adults in the United States (47 percent, or 116 million) have hypertension, also known as high blood pressure (BP). Uncontrolled high BP can be devasting as it can lead to stroke, heart attack and kidney failure, as well as other numerous health conditions. Hypertension can be controlled; however, only one in four of adults with hypertension have their BP controlled. The chance of having high BP increases as one ages, requiring the need to examine effective hypertension strategies in older adults. The issue of hypertension management is compounded even further among older U.S. adults who live with multiple chronic diseases.
Read full original descriptionShow less
National organizations identified several effective health systems strategies for improving rates of BP control, including patient self-measured blood pressure (SMBP) monitoring. SMBP involves a patient's regular use of personal BP monitoring devices to assess and record BP across different points in time, typically at home. The evidence base for utilizing SMBP strategies in healthcare systems and practices is strong. However, there is not research regarding SMBP including how to include it into workflow in primary care clinics. Previous research has shown SMBP is beneficial, but more information is needed regarding whether SMBP is beneficial in high-risk populations (such as rural, older adults or Black, older patients).
The research team will test whether SMBP with normal clinical support vs SMBP with clinical pharmacist support improves BP in older adults living with multiple chronic conditions. The addition of a pharmacist has been shown to improve patient outcomes, though the effectiveness of SMBP with a clinical pharmacist in older adults is not known. The primary outcome will be change in systolic BP over 12 months. The secondary outcome will be self-reported treatment burden over 12 months, using a validated tool called the Multimorbidity Treatment Burden Questionnaire. The research team plans to include a subgroup of rural, older adults and Black, older adults and will not exclude older adults who have dementia.
The 2 groups in the trial
- SMBP-pharmacistTreatment being tested
Self-measured blood pressure with clinical pharmacist support
Treatment: SMBP with clinical pharmacist support
- SMBP-conventionalNo study treatment, for comparison
Self-measured blood pressure with conventional clinical support
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Improving High Blood Pressure in Older Adults Living With Multiple Chronic Diseases - The SMBP Study
- Plain-language title
- Tests home blood pressure monitoring with pharmacist help in older adults with chronic diseasesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 October 2025